Lapatinib vs trastuzumab in combination with standard EC-D chemotherapy in the neaodjuvant treatment of HER2+ patients. Results from the GEICAM 2006-14 phase II randomized trial

Calvo Martínez, Lourdes

Statistics

Statistics

View Usage Statistics

Identifiers

Identifiers

URI: http://hdl.handle.net/20.500.11940/2682

DOI: 10.1158/0008-5472.SABCS11-PD07-04

ISSN: 0008-5472

Full record

Services

Services

RIS

Mendeley

Linksolver

Date issued

2011

Journal title

CANCER RESEARCH

Type of content

Publicación de congreso